Finally, our conclusions are based on cross-sectional measurements and correlations without functional validation of how the TIGIT/CD155 axis affects effector activity in CRC, and differences between mRNA and protein regulation, as well as pre-analytical factors (tissue composition, variable stromal content, and protein stability) may influence protein concentrations measured in homogenates. This evidence concerns the gene PVR and colorectal carcinoma.